ArticleClinical oral investigations2025
Discriminating bacterial types in oral and maxillofacial space infections (OMSIs) via smelling diagnosis.
Article in Clinical oral investigations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Analysis of pathogenic bacteria of oral and maxillofacial space infection and the effect of vacuum sealing drainage treatment.American journal of translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectivesTo explore the feasibility of using gas chromatography-mass spectrometry (GC-MS) in the diagnosis of bacterial types of oral and maxillofacial space infections (OMSIs).
methodsStaphylococcus aureus was cultured to produce a full spectrum of volatile organic compounds (VOCs). These VOCs were collected and identified using VOC collectors and GC-MS. A bacteria Probability-based VOC Algorithm (BPVA) was developed to assess the likelihood of infection in vivo utilizing a rat model. VOCs from 19 clinical OMSIs abscess samples were analyzed to calculate the probability of SA infection, with results validated against traditional culture results.
resultsUsing fold change (FC), p-values (P), and variable importance in projection (VIP) values, we identified 318 characteristic target compounds associated with Staphylococcus aureus. After fitting these compounds to the rat infection model, 189 compounds were selected, establishing a BPVA threshold of ≥ 50, with a 95% probability of consistency. Four patients exhibited an SA infection probability exceeding 70%, whereas the other patients fell below this threshold. Clinical results confirmed SA infections in these four patients, with detection times reduced to approximately 24 h, significantly shorter than the typical 3-5 days.
conclusionsThe combination of GC‒MS and BPVA significantly accelerated the diagnosis of bacterial types in OMSIs, demonstrating strong agreement with traditional culture results, highlighting a new method to accurately and rapidly diagnose maxillofacial infections. CLINICAL RELEVANCE: Rapid identification of bacterial types is essential for treating OMSIs. However, current bacterial culture methods face challenges, such as limited accuracy and time-consuming processes.
Indexed as
Identifiers
39998688What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.